Regarding uterine LMS and endometrial stromal sarcoma, the expression of estrogen receptor (ER) and progesterone receptor (PR) was frequently observed in previous studies using immunohistochemistry. This evidence concerns the gene ESR1 and endometrioid stromal sarcoma.